IMRX - TD Cowen cuts Immuneering to market perform cites Phase 1 data March, 15 2024 11:36 AM Immuneering Corporation 2024-03-15 11:36:41 ET More on Immuneering Immuneering cancer drug shows initial clinical activity in early-stage trial Seeking Alpha’s Quant Rating on Immuneering Historical earnings data for Immuneering Financial information for Immuneering For further details see: TD Cowen cuts Immuneering to market perform, cites Phase 1 data